GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients kblankenship Thu, 09/10/2020 – 08:37

AstraZeneca chases GSK, Sanofi and Regeneron with Fasenra trial win in nasal polyps aliu Thu, 09/10/2020 – 09:44

Roche’s new approval Enspryng cuts relapse risk in NMOSD—and provides extended benefits esagonowsky Thu, 09/10/2020 – 09:55

The UK government grant will support new and existing advanced therapy projects until March 2022

The proposed deal covers the initial supply of 200 million doses and an option to purchase an additional […]

The EMA has asked for full data from an ongoing Phase III study of the treatment in patients […]

Trelegy Ellipta is now the first once-daily single inhaler triple therapy for the treatment of both asthma and […]

Researchers in the COVID-19 ‘hot spot’ in the Tyrolean region of Austria recruited consecutive coronavirus patients to their […]

Loss of strength and muscle wastage is currently an unavoidable part of getting older and has a significant […]

Updated Date: Wed, 02 Sep 2020 00:00:00 EDT